Paragonix Tech wins CE Mark for heart transport devices

Paragonix Technologies said today it won CE Mark approval in the European Union for its SherpaPak and SherpaPerfusion cardiac transport systems. The SherpaPak system consists of a single-use, disposable device designed for the hypothermic static preservation and transportation of the donor hearts, while the SherpaPerfusion system is a single-use, disposable device designed for hypothermic oxygenated perfusion preservation and transport of donor hearts. “Having followed the extensive research and product development activities at Paragonix Technologies over the past few years, I am impressed by the intuitive designs of both SherpaPak and SherpaPerfusion Cardiac Transport Systems. They directly address all relevant issues of improving donor heart preservation at hypothermia. We look forward to incorporating both donor heart preservation systems at our transplant center,” Dr. Andreas Zuckermann of Austria’s University of Vienna said in prepared remarks. The current standard of care for donor heart preservation and transport includes placing the organs in fluid-filled sterile bags placed on crushed ice within an ice chest, and can lead to temperatures below 2 degrees celsius which the Braintree, Mass.-based company said can increase the risk of cold injury and frostbite. The SherpaPak and SherpaPerfusion technologies are designed to remove this risk and improve the quality of the organ transportation, the company said. “I am excited about the European avai...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiovascular Regulatory/Compliance Surgical Transplants Paragonix Technologies Source Type: news